Loading...
In the U.S., more than 30% of hysterectomies are performed to treat uterine leiomyomata. In this multicenter, industry-supported trial, researchers examined outcomes among 109 women with symptomatic leiomyomata who underwent a new alternative to hysterectomy: leiomyomata thermoablation by magnetic-resonance–guided focused ultrasound. Thermocoagulation was limited to 100 cm3 per fibroid, and treatment was limited to 3 hours. The primary endpoint was a 10-point improvement on a validated 100-point scale assessing bleeding and bulk-related symptoms.
A mean of 1.3 fibroids per patient were treated (mean volume of each fibroid, 284.7 cm3; mean volume coagulated per fibroid, 25.6 cm3). Ten-point symptom improvements were noted in 77 of 109 patient…